LIPOCINE INC.
Income Statement
| Line Item | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $428.0K | $0 | $0 | — | — | $0 | $7.7M | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| Gross Margin | — | — | — | — | — | — | — | — |
| Operating Expenses | ||||||||
| Research & Development | $6.5M | $11.0M | $8.1M | $12.6M | $15.5M | $5.1M | $2.3M | — |
| SG&A Expense | $5.3M | $10.2M | $10.4M | $5.8M | $5.0M | $3.6M | $1.6M | $5.2K |
| Operating Income | $-11.3M | $-21.2M | $-19.2M | $-18.4M | $-20.5M | $-10.7M | $3.9M | — |
| Operating Margin | -2,646.0% | — | — | — | — | — | 50.3% | — |
| Interest Expense | — | — | — | — | — | — | — | — |
| Pretax Income | $-11.7M | $-21.0M | $-19.0M | $-18.2M | $-20.4M | $-10.6M | $3.9M | — |
| Income Tax Expense | $700 | $700 | $752 | $200 | $200 | $-55.0K | $684 | — |
| Net Income | $-11.7M | $-21.0M | $-19.0M | $-18.2M | $-20.4M | $-10.6M | $3.9M | $-5.2K |
| Net Margin | -2,724.1% | — | — | — | — | — | 50.4% | — |
| EPS (Basic) | $-0.28 | $-0.53 | $-0.52 | $-0.56 | $-0.80 | $-0.72 | $0.43 | — |
| EPS (Diluted) | $-0.28 | $-0.53 | $-0.52 | $-0.56 | $-0.80 | $-0.72 | $0.43 | — |
| Shares Outstanding (Basic) | 42.7M | 40.1M | 36.5M | 32.9M | 25.5M | 14.7M | 8.9M | 6.0M |
| Shares Outstanding (Diluted) | 42.7M | 40.1M | 36.5M | 32.9M | 25.5M | 14.7M | 8.9M | 6.0M |
| Dividends Per Share | — | — | — | — | — | — | — | — |